← Leaderboards
Theodore Lee Roth
University Of California, San Francisco
$2,016,040
Attributed
$2,016,040
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.6M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,016,040 · 3
By mechanism
DP2$1,413,277 · 1
K08$538,799 · 1
F30$63,964 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Hideho Okada$20,052,698
- Mark S Anderson$96,401,564
- Lawrence Fong$19,816,074
- Jason G. Cyster$29,153,268
- David Wofsy$36,586,558
Others in their field
Other Emerging Leaders on “Cells”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$155,695,588
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Evan Z Macosko · Broad Institute, Inc.$33,096,828
- James Dale Berry · Brigham And Women'S Hospital$30,122,905
- Hanjoon Ryu$28,519,898
- Eric C Palm · Florida State University$26,502,247
Research focus
CellsEngineeringCell PhysiologyCell TherapyImmuneMalignant NeoplasmsGeneticT-LymphocyteCancer ImmunotherapyKnock-InIn VitroIn VivoTumorEnvironmentFoundationsGene TargetingT Cell TherapyCellular ImmunotherapyChimeric Antigen ReceptorClinical TrialsTrainingModificationGenomeScreening
Grant awards (5)
Synthetic Cell State Engineering for Primary Human Cellular Therapies$1,413,277
DP2 · FY2025 · CA · contact PI
Dissecting intrinsic variability in engineered T Cell immunotherapies$207,857
K08 · FY2025 · CA · contact PI
Dissecting intrinsic variability in engineered T Cell immunotherapies$330,942
K08 · FY2024 · CA · contact PI
Endogenous T Cell Receptor Replacement in Autoimmune Diabetes$38,915
F30 · FY2020 · DK · contact PI
Endogenous T Cell Receptor Replacement in Autoimmune Diabetes$25,049
F30 · FY2018 · DK · contact PI